FindTrial
Sign In

Gut microbiome in children with gastrointestinal disease

Gut microbiome in children with gastrointestinal disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008372
Enrollment
120
Registered
2023-04-21
Start date
2020-11-26
Completion date
Unknown
Last updated
2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Koera University Guro Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) IBD patients aged 13-25 years who were diagnosed with inflammatory bowel disease with onset under the age of 17, or undergoing treatment. 2) IBS patients aged 13-25 years who were diagnosed with irritable bowel syndrome with onset under the age of 17.

Exclusion criteria

Exclusion criteria: Individuals who do not consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
Alpha and beta diversity as well as composition of gut microbiota: 1) The characteristics of gut microbiota in pediatric patients with IBD will be analyzed in comparison to healthy individuals and those with IBS. 2) Differences in gut microbiota at the time of diagnosis or exacerbation of IBD will be analyzed for clinical relevance—

Secondary

MeasureTime frame
IBD group: clinical severity score (PCDAI, PUCAI);IBD group: endoscopic severity score (SES-CD, UCEIS);IBD/IBS group: fecal calprotectin;IBD group: use of biologics—

Countries

Korea, Republic of

Contacts

Public ContactJung Ok Shim

Koera University Guro Hospital

shimjo@korea.ac.kr@shimjo@korea.ac.kr+82-2-2626-3157

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026